Medical Editor June 7, 2022 Gilead breast cancer drug cuts disease progression, improves survival by 59% (NASDAQ:GILD) – Seeking Alpha Gilead breast cancer drug cuts disease progression, improves survival by 59% (NASDAQ:GILD) Seeking Alpha